Complications of cyclophosphamide therapy
| ISSN: |
1434-4726
|
|---|---|
| Keywords: |
Cyclophosphamide ; Toxicity ; Autoimmune disease ; Vasculitis ; Wegener's granulomatosis
|
| Source: |
Springer Online Journal Archives 1860-2000
|
| Topics: |
Medicine
|
| Notes: |
Abstract Cyclophosphamide is a powerful immunosuppressive agent that is commonly used clinically to treat neoplastic and inflammatory diseases affecting various sites, including the head and neck. The pharmacology of cyclophosphamide is reviewed with an emphasis on its toxicities and strategies for minimizing therapeutic adverse effects. Principles of therapy are discussed and illustrated by the use of cyclophosphamide in the treatment of Wegener's granulomatosis, a form of systemic vasculitis with prominent head and neck manifestations.
|
| Type of Medium: |
Electronic Resource
|
| URL: |
| _version_ | 1798296089055461377 |
|---|---|
| autor | Langford, C. A. |
| autorsonst | Langford, C. A. |
| book_url | http://dx.doi.org/10.1007/BF01526181 |
| datenlieferant | nat_lic_papers |
| hauptsatz | hsatz_simple |
| identnr | NLM20405236X |
| issn | 1434-4726 |
| journal_name | European archives of oto-rhino-laryngology and head & neck |
| materialart | 1 |
| notes | Abstract Cyclophosphamide is a powerful immunosuppressive agent that is commonly used clinically to treat neoplastic and inflammatory diseases affecting various sites, including the head and neck. The pharmacology of cyclophosphamide is reviewed with an emphasis on its toxicities and strategies for minimizing therapeutic adverse effects. Principles of therapy are discussed and illustrated by the use of cyclophosphamide in the treatment of Wegener's granulomatosis, a form of systemic vasculitis with prominent head and neck manifestations. |
| package_name | Springer |
| publikationsjahr_anzeige | 1997 |
| publikationsjahr_facette | 1997 |
| publikationsjahr_intervall | 8004:1995-1999 |
| publikationsjahr_sort | 1997 |
| publisher | Springer |
| reference | 254 (1997), S. 65-72 |
| schlagwort | Cyclophosphamide Toxicity Autoimmune disease Vasculitis Wegener's granulomatosis |
| search_space | articles |
| shingle_author_1 | Langford, C. A. |
| shingle_author_2 | Langford, C. A. |
| shingle_author_3 | Langford, C. A. |
| shingle_author_4 | Langford, C. A. |
| shingle_catch_all_1 | Langford, C. A. Complications of cyclophosphamide therapy Cyclophosphamide Toxicity Autoimmune disease Vasculitis Wegener's granulomatosis Cyclophosphamide Toxicity Autoimmune disease Vasculitis Wegener's granulomatosis Abstract Cyclophosphamide is a powerful immunosuppressive agent that is commonly used clinically to treat neoplastic and inflammatory diseases affecting various sites, including the head and neck. The pharmacology of cyclophosphamide is reviewed with an emphasis on its toxicities and strategies for minimizing therapeutic adverse effects. Principles of therapy are discussed and illustrated by the use of cyclophosphamide in the treatment of Wegener's granulomatosis, a form of systemic vasculitis with prominent head and neck manifestations. 1434-4726 14344726 Springer |
| shingle_catch_all_2 | Langford, C. A. Complications of cyclophosphamide therapy Cyclophosphamide Toxicity Autoimmune disease Vasculitis Wegener's granulomatosis Cyclophosphamide Toxicity Autoimmune disease Vasculitis Wegener's granulomatosis Abstract Cyclophosphamide is a powerful immunosuppressive agent that is commonly used clinically to treat neoplastic and inflammatory diseases affecting various sites, including the head and neck. The pharmacology of cyclophosphamide is reviewed with an emphasis on its toxicities and strategies for minimizing therapeutic adverse effects. Principles of therapy are discussed and illustrated by the use of cyclophosphamide in the treatment of Wegener's granulomatosis, a form of systemic vasculitis with prominent head and neck manifestations. 1434-4726 14344726 Springer |
| shingle_catch_all_3 | Langford, C. A. Complications of cyclophosphamide therapy Cyclophosphamide Toxicity Autoimmune disease Vasculitis Wegener's granulomatosis Cyclophosphamide Toxicity Autoimmune disease Vasculitis Wegener's granulomatosis Abstract Cyclophosphamide is a powerful immunosuppressive agent that is commonly used clinically to treat neoplastic and inflammatory diseases affecting various sites, including the head and neck. The pharmacology of cyclophosphamide is reviewed with an emphasis on its toxicities and strategies for minimizing therapeutic adverse effects. Principles of therapy are discussed and illustrated by the use of cyclophosphamide in the treatment of Wegener's granulomatosis, a form of systemic vasculitis with prominent head and neck manifestations. 1434-4726 14344726 Springer |
| shingle_catch_all_4 | Langford, C. A. Complications of cyclophosphamide therapy Cyclophosphamide Toxicity Autoimmune disease Vasculitis Wegener's granulomatosis Cyclophosphamide Toxicity Autoimmune disease Vasculitis Wegener's granulomatosis Abstract Cyclophosphamide is a powerful immunosuppressive agent that is commonly used clinically to treat neoplastic and inflammatory diseases affecting various sites, including the head and neck. The pharmacology of cyclophosphamide is reviewed with an emphasis on its toxicities and strategies for minimizing therapeutic adverse effects. Principles of therapy are discussed and illustrated by the use of cyclophosphamide in the treatment of Wegener's granulomatosis, a form of systemic vasculitis with prominent head and neck manifestations. 1434-4726 14344726 Springer |
| shingle_title_1 | Complications of cyclophosphamide therapy |
| shingle_title_2 | Complications of cyclophosphamide therapy |
| shingle_title_3 | Complications of cyclophosphamide therapy |
| shingle_title_4 | Complications of cyclophosphamide therapy |
| sigel_instance_filter | dkfz geomar wilbert ipn albert fhp |
| source_archive | Springer Online Journal Archives 1860-2000 |
| timestamp | 2024-05-06T09:46:33.254Z |
| titel | Complications of cyclophosphamide therapy |
| titel_suche | Complications of cyclophosphamide therapy |
| topic | WW-YZ |
| uid | nat_lic_papers_NLM20405236X |